About Eskag Pharma Pvt Ltd
Data last updated:
Eskag Pharma Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 1977 and has been in existence for over 49 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24234WB1977PTC030897. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1.8 Cr and a paid-up capital of ₹1.68 Cr. It is led by directors Anil Kumar Agarwal and Sunil Kumar Agarwal.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ag – 112 Unit No – 4 8th Flooor Baisakhi Sector – II Saltlake, Kolkata, West Bengal, India – 700091.
As per the financials filed for FY 2025, the company reported a revenue of ₹82.92 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹8.34 Cr (net margin 10.1%) and EBITDA of ₹17.83 Cr (EBITDA margin 21.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The company has about 594 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Eskag Sanjeevani and Eskag Pharma. As per MCA filings, the company has open charges of ₹126.84 Cr and satisfied charges of ₹35.15 Cr on record. Court records list 29 cases involving the company, including 17 filed by the company and 12 filed against it; 15 cases are pending. The company has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹10.21 Cr; the latest was in November 2023. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Universal Medicare Private Limited with revenue of ₹77.59 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eskag.in.
Company details
Contact details
Eskag Pharma Pvt Ltd's registered office is in Kolkata, West Bengal. Its website is eskag.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressAg – 112 Unit No – 4 8th Flooor Baisakhi Sector – II Saltlake, Kolkata, West Bengal, India – 700091
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eskag Pharma Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eskag Pharma operates two associated brands: Eskag Sanjeevani and Eskag Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates as a standalone multi-speciality hospital offering comprehensive medical care. | eskagsanjeevani.com | |
| Manufactures and supplies pharmaceutical products for therapeutic areas like dermatology and gastroenterology. | eskag.in |
Business activity
The main business activity of Eskag Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Eskag Pharma Pvt Ltd, buy the company report.
Financials of Eskag Pharma Pvt Ltd
FY 2025 filings availableEskag Pharma Pvt Ltd reported revenue of ₹82.92 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 8% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹82.92 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.83 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.34 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | ||||
| Net Profit Margin | 10.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eskag Pharma Pvt Ltd, buy the company report.
Board of directors of Eskag Pharma Pvt Ltd
Eskag Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Agarwal Also directs: Upashaya Healthcare LLP, Wbcil (Dahej) Limited, West Bengal Chemical Industries Ltd. and 5 more | Director | 11 May 2005 | 21 Years 5 Months | Current |
| Sunil Kumar Agarwal Also directs: Wbcil (Dahej) Limited, West Bengal Chemical Industries Ltd., Bhagirathi Commodities Private Limited and 5 more | Director | 13 Jun 1984 | 42 Years 4 Months | Current |
Peer comparison
Eskag Pharma Pvt Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eskag Pharma Pvt Ltdthis company | ₹82.92 Cr (FY 2025) | ₹8.34 Cr | 10.1% | 8.0% | 594 | Kolkata, West Bengal, India |
| Universal Medicare Private Limited | ₹77.59 Cr (FY 2025) | 38.0% | Mumbai, Maharashtra, India | |||
| Asence Pharma Private Limited | ₹77.56 Cr (FY 2025) | 19.0% | Vadodara, Gujarat, India | |||
| Vasa Pharma Chem Pvt Ltd | ₹77.38 Cr (FY 2025) | -8.0% | Ahmedabad, Gujarat, India | |||
| Vapi Care Pharma Private Limited | ₹76.81 Cr (FY 2025) | -11.0% | Vapi, Valsad, Gujarat, India | |||
| Mercury Laboratories Limited | ₹76.17 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Vovantis Laboratories Private Limited | ₹76.05 Cr (FY 2025) | 67.0% | Vadodara, Gujarat, India | |||
| Higlance Laboratories Private Limited | ₹75.98 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Vital Therapeutics and Formulations Private Limited | ₹75.96 Cr (FY 2024) | 2.0% | Hyderabad, Telangana, India | |||
| Bennet Pharmaceuticals Limited | ₹75.82 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Eskag Pharma Pvt Ltd, buy the company report.
Auditor
Eskag Pharma Pvt Ltd is audited by MAHENDRA SUBHAS & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAHENDRA SUBHAS & CO | FY 2024 | 0324346E |
Shareholding
The shareholding of Eskag Pharma Pvt Ltd is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eskag Pharma Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jan 2023 | 100665623 | Standard Chartered Bank | ₹15 Cr | Open | |
| 28 Jun 2021 | 100457268 | Standard Chartered Bank | ₹17.57 Cr | Open | |
| 21 Jan 2020 | 100322930 | Hdfc Bank Limited | ₹77.58 Cr | Open | |
| 29 Dec 2018 | 100241747 | Others | ₹44.5 Lakh | Open | |
| 02 Feb 2018 | 100159543 | Hdfc Bank Limited | ₹13.4 Cr | Open |
To see the full charge records of Eskag Pharma Pvt Ltd, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Eskag Pharma Pvt Ltd has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹10.21 Cr; the latest was in November 2023.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2014 | Funding round | ₹1.4 Cr | Investors: Godavari Dealcom Private Limited |
| Mar 2013 | Funding round | ₹1.82 Cr | Investors: Godavari Dealcom Private Limited , Vipasa Agency Private Limited , Tirupati Metals Pvt Ltd |
| Mar 2012 | Funding round | ₹2.42 Cr | Investors: Vipasa Agency Private Limited |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Tirupati Metals Pvt Ltd Seller: Dhanterash Dealers Private Limited, Kanhaiya Distributors Private Limited , Panghat Vinimay Private Limited |
| Mar 2010 | Funding round | ₹2 Cr | Investors: Arihant Corporate Consultant Private Limited, Shagun Tie-Up Pvt Ltd , Jay Raj Commodities Pvt Ltd |
To see the full deal history of Eskag Pharma Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Eskag Pharma Pvt Ltd has 29 court cases on record: 17 filed by Eskag Pharma, 12 filed against it. 15 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 3 | 5 |
| District courts | 12 | 6 | 8 |
| NCLAT | 3 | 2 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed against the company by Next Radio Ltd and 1 other | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed against the company by HT Media Ltd. and Others | Pending |
| District court, North Twenty Four Parganas, West Bengal | Criminal complaint | Filed by the company against Leisha Pharma Solutions Pvt. Ltd. | Disposed |
| NCLAT, NCLAT New Delhi | Company appeal | Filed by the company against Vipasa Agency Pvt Ltd and 18 others | Disposed |
| High Court, UTTARPRADESH | Court case (ARCO) | Filed against the company by M/S Avadh Pharma Pvt Ltd. | Disposed |
To see the full case history of Eskag Pharma Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eskag Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eskag Pharma Pvt Ltd has a workforce of 594 employees on its EPFO records as of Oct 09, 2025, across 2 active EPFO establishments.
GST
Eskag Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Eskag Pharma Pvt Ltd, buy the company report.
Recent activity
Eskag Pharma Pvt Ltd has 3 board changes on record since 1984: 2 appointments and 1 cessation. The latest: Sushil Kumar Agarwal ceased to be Director on 21 Jun 2014.
18 earlier events are in the company report.
Frequently asked questions
Eskag Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 February 1977 (49+ years old) and is registered under CIN U24234WB1977PTC030897.
Eskag Pharma has 2 current directors:
- Anil Kumar Agarwal - Director
- Sunil Kumar Agarwal - Director
The latest financial statements of Eskag Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
No. Eskag Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Eskag Pharma is U24234WB1977PTC030897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eskag Pharma has 29 court cases on record: 17 filed by the company and 12 filed against it. 15 are pending. Most are in the high courts.
Eskag Pharma was incorporated on 24 February 1977, making it 49+ years old. It is registered with the Registrar of Companies, Kolkata.
Eskag Pharma has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹10.21 Cr; the latest was in November 2023.
The peers of Eskag Pharma by revenue are Universal Medicare Private Limited, Asence Pharma Private Limited, Vasa Pharma Chem Pvt Ltd, Vapi Care Pharma Private Limited, Mercury Laboratories Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sushil Kumar Agarwal ceased to be Director on 21 Jun 2014. Anil Kumar Agarwal was appointed as Director on 11 May 2005. Sunil Kumar Agarwal was appointed as Director on 13 Jun 1984.
Eskag Pharma can be reached through the website eskag.in. Its registered office is in Kolkata, West Bengal, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
